BZW1 (basic leucine zipper and W2 domains 1) is a translation initiation regulatory protein that plays crucial roles in both normal cellular processes and tumorigenesis. The protein functions primarily as a competitive inhibitor of eukaryotic translation initiation factor 5 (EIF5), specifically repressing repeat-associated non-AUG (RAN) initiated translation while promoting accurate AUG-dependent translation initiation 1. BZW1 is essential for early embryonic development, particularly during preimplantation stages where it regulates compaction and blastocyst formation by restricting non-AUG translational initiation 1. In cancer contexts, BZW1 is consistently overexpressed across multiple tumor types including pancreatic ductal adenocarcinoma, prostate cancer, glioma, and lung adenocarcinoma, where high expression correlates with poor prognosis 2345. Mechanistically, BZW1 promotes tumorigenesis through multiple pathways: it facilitates glycolysis by serving as an adaptor for PERK, promoting eIF2α phosphorylation and subsequent HIF1α/c-Myc translation 2; it activates TGF-β1/Smad signaling to enhance cell proliferation 3; and it contributes to metabolic reprogramming and endoplasmic reticulum stress responses 6. Clinically, BZW1 represents a promising therapeutic target and prognostic biomarker, with its expression levels correlating with tumor progression, metastasis, and patient survival outcomes across various cancer types 7.